Arctic Bioscience AS

Arctic Bioscience AS Equity

The The Equity of Arctic Bioscience AS (ABS.OL) as of Oct 14, 2026 is 173.49 M NOK. In the previous year, The Equity was 210.73 M NOK — a change of -17.67% (lower).

Equity

173.49 MNOK

YoY

-17.67%

Last updated:

In 2025, Arctic Bioscience AS's equity was 173.49 M NOK, a -17.67% increase from the 210.73 M NOK equity in the previous year.

The Arctic Bioscience AS Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
21.89 M NOK
Jan 1, 2019
63.90 M NOK
Jan 1, 2020
63.94 M NOK
Jan 1, 2021
320.55 M NOK
Jan 1, 2022
287.28 M NOK
Jan 1, 2023
258.56 M NOK
Jan 1, 2024
210.73 M NOK
Jan 1, 2025
173.49 M NOK
The Arctic Bioscience AS Equity history
YEAREquityYoY
173.49 MNOK-17.67%
210.73 MNOK-18.50%
258.56 MNOK-10.00%
287.28 MNOK-10.38%
320.55 MNOK+401.34%
63.94 MNOK+0.07%
63.90 MNOK+191.95%
21.89 MNOK—
Access this data via the Eulerpool API
Get Free API Key

Arctic Bioscience AS Stock analysis

What does Arctic Bioscience AS do? Arctic Bioscience AS is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Arctic Bioscience AS's Equity

Arctic Bioscience AS's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arctic Bioscience AS's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Arctic Bioscience AS's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Arctic Bioscience AS's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Arctic Bioscience AS’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Arctic Bioscience AS stock

The Equity of Arctic Bioscience AS is 173.49 M NOK in 2025.

The Equity of Arctic Bioscience AS changed from 210.73 M NOK to 173.49 M NOK, representing a -17.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Arctic Bioscience AS since 2006 – with annual values, charts, and detailed analysis.

The Equity's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Arctic Bioscience AS historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Arctic Bioscience AS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Arctic Bioscience AS